Serological diagnosis of idiopathic pulmonary alveolar proteinosis

被引:146
作者
Kitamura, T
Uchida, K
Tanaka, N
Tsuchiya, T
Watanabe, J
Yamada, Y
Hanaoka, K
Seymour, JF
Schoch, OD
Doyle, I
Inoue, Y
Sakatani, M
Kudoh, S
Azuma, A
Nukiwa, T
Tomita, T
Katagiri, M
Fujita, A
Kurashima, A
Kanegasaki, S
Nakata, K
机构
[1] Int Med Ctr Japan, Inst Res, Dept Pulm Dis, Shinjuku Ku, Tokyo 1628655, Japan
[2] Kitasato Univ, Sch Med, Kanagawa, Japan
[3] Univ Tokyo, Fac Med, Dept Anesthesiol, Tokyo 113, Japan
[4] Ludwig Inst Canc Res, Parkville, Vic, Australia
[5] Univ Zurich Hosp, CH-8091 Zurich, Switzerland
[6] Flinders Univ S Australia, Bedford Pk, SA 5042, Australia
[7] Natl Kinki Chuo Hosp, Osaka, Japan
[8] Nippon Med Sch, Tokyo 113, Japan
[9] Tohoku Univ, Inst Dev Aging & Canc, Sendai, Miyagi 980, Japan
[10] Tokyo Metropolitan Fuchu Hosp, Tokyo, Japan
[11] Natl Tokyo Hosp, Tokyo, Japan
关键词
D O I
10.1164/ajrccm.162.2.9910032
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Previously, we reported the specific occurrence of neutralizing autoantibodies against granulocyte-macrophage colony-stimulating factor (GM-CSF) in the bronchoalveolar ravage fluid from 11 Japanese patients with idiopathic pulmonary alveolar proteinosis (I-PAP). The autoantibody was also detected in sera from all 5 I-PAP patients examined. To determine that the existence of the autoantibody is not limited to the Japanese patients, we examined sera from 24 I-PAP patients in five countries and showed that the autoantibody was consistently and specifically present in such patients. Thus, detection of the autoantibody in sera can be used for diagnosis of I-PAP. To establish a simple and convenient method for diagnosis of I-PAP, we developed a novel latex agglutination test using latex beads coupled with recombinant human CM-CSF. GM-CSF binding proteins isolated from the sera using the latex beads were identified as the autoantibodies of IgG(1) and IgG(2). The titer of the autoantibody determined by this test correlated with that determined by ELISA. Agglutination was positive in 300-fold diluted sera from all 24 I-PAP patients, but negative in sera from four secondary PAP patients, two congenital PAP patients, 40 patients with other lung diseases, and 38 of 40 normal subjects. These results establish that the latex agglutination test is a reliable method for serological diagnosis of I-PAP with high sensitivity (100%) and specificity (98%).
引用
收藏
页码:658 / 662
页数:5
相关论文
共 18 条
[1]   Bronchoalveolar lavage fluid composition in alveolar proteinosis - Early changes after therapeutic lavage [J].
Alberti, A ;
Luisetti, M ;
Braschi, A ;
Rodi, G ;
Iotti, G ;
Sella, D ;
Poletti, V ;
Benori, V ;
Baritussio, A .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1996, 154 (03) :817-820
[2]   Surfactant protein A is degraded by alveolar macrophages [J].
Bates, SR ;
Fisher, AB .
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY, 1996, 271 (02) :L258-L266
[3]  
BORDOW RA, 1985, MANUAL CLIN PROBLEMS, P393
[4]   Degradation of surfactant protein D by alveolar macrophages [J].
Dong, Q ;
Wright, JR .
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY, 1998, 274 (01) :L97-L105
[5]   Idiopathic pulmonary alveolar proteinosis as an autoimmune disease with neutralizing antibody against granulocyte/macrophage colony-stimulating factor [J].
Kitamura, T ;
Tanaka, N ;
Watanabe, J ;
Uchida, K ;
Kanegasaki, S ;
Yamada, Y ;
Nakata, K .
JOURNAL OF EXPERIMENTAL MEDICINE, 1999, 190 (06) :875-880
[6]   ESTABLISHMENT AND CHARACTERIZATION OF A UNIQUE HUMAN CELL-LINE THAT PROLIFERATES DEPENDENTLY ON GM-CSF, IL-3, OR ERYTHROPOIETIN [J].
KITAMURA, T ;
TANGE, T ;
TERASAWA, T ;
CHIBA, S ;
KUWAKI, T ;
MIYAGAWA, K ;
PIAO, YF ;
MIYAZONO, K ;
URABE, A ;
TAKAKU, F .
JOURNAL OF CELLULAR PHYSIOLOGY, 1989, 140 (02) :323-334
[7]  
KUROKI Y, 1994, J BIOL CHEM, V269, P25943
[8]   DEGRADATION OF PULMONARY SURFACTANT DISATURATED PHOSPHATIDYLCHOLINES BY ALVEOLAR MACROPHAGES [J].
MILES, PR ;
MA, JYC ;
BOWMAN, L .
JOURNAL OF APPLIED PHYSIOLOGY, 1988, 64 (06) :2474-2481
[10]   INDUCTION OF ANTI-RECOMBINANT HUMAN GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR (ESCHERICHIA COLI-DERIVED) ANTIBODIES AND CLINICAL EFFECTS IN NONIMMUNOCOMPROMISED PATIENTS [J].
RAGNHAMMAR, P ;
FRIESEN, HJ ;
FRODIN, JE ;
LEFVERT, AK ;
HASSAN, M ;
OSTERBORG, A ;
MELLSTEDT, H .
BLOOD, 1994, 84 (12) :4078-4087